Medicine pills, white balance 3000K

Vumerity approved for PBS listing for relapsing-remitting MS

Today, the Federal Health and Aged Care Minister announced the listing of Vumerity® (diroximel fumarate) on the Pharmaceutical Benefits Scheme (PBS) for the treatment of Australians living with relapsing remitting MS (RRMS).

Managing MS pain and the mind-body connection

National Pain Week (July 25 to 31) is an annual event coordinated by Chronic Pain Australia. Pain is one of the less recognised symptoms of multiple sclerosis but affects around two-thirds of the over 25,600 Australians living with the disease.
50 Years of Multiple Sclerosis Australia

Is the end in sight? MS research holds great promise

This year marks the 50th year of Multiple Sclerosis Australia, an organisation formed to drive awareness, research, and support for people with multiple sclerosis (MS).
Rohan Greenland The May 50K

From our CEO

As we mark our 50th year, it's deeply encouraging to look at how far we have come over the past five decades and acknowledge the great changes that have taken place to improve the quality of life for people living with MS.

MS on the rise in Hobart

Epidemiological research shows that MS in the Greater Hobart area is on the rise.
B-cell and antibodies, 3D illustration

Does Epstein Barr virus in early MS bias the immune system towards brain inflammation?

A new study seeks to understand the role of B cells and EBV in the development of MS.

Our vision

A world without MS

Read More

Newsletter subscription

  • Enter your details